Trial Profile
Phase I trial of autologous stem cell therapy [AMR 001; Amorcyte] in patients with congestive heart failure.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2012
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 16 Aug 2012 New trial record